As of 05/15/2025, BioNexus Gene Lab Corp.'s market capitalization has reached $5.34 M. According to our data, BioNexus Gene Lab Corp. is the 42365th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
BioNexus Gene Lab Corp. has seen its market value drop from $236.28 M to $5.34 M since 2020, representing a total decrease of 97.74% and an annual compound decline rate (CAGR) of 57.99%.
Date
Market Cap
Change (%)
05/15/2025
$5.34 M
-4.55%
12/31/2024
$5.03 M
-46.33%
12/29/2023
$9.36 M
-94.33%
12/30/2022
$165.03 M
-54.75%
12/31/2021
$364.69 M
54.35%
12/31/2020
$236.28 M
Company Profile
BioNexus Gene Lab Corp. was founded in 2017 in Malaysia.
on the Nasdaq Stock Market.
With 30 employees, it focuses on Materials and aims to drive innovation in Specialty Chemicals.
Frequently Asked Questions
As of 05/15/2025, BioNexus Gene Lab Corp. (including the parent company, if applicable) has an estimated market capitalization of $5.34 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
BioNexus Gene Lab Corp. global market capitalization ranking is approximately 42365 as of 05/15/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.